Golden Capital News | U.S. stocks performed positively on Thursday, with strong U.S. data and significant stimulus measures introduced by China, bullish sentiment in the major market, all three major indices recorded gains at the close. The U.S. dollar fluctuated downwards, U.S. ten-year bond yields remained at 3.79%, gold prices hit new highs again, and oil prices remained soft. Hong Kong stocks generally rose, with expectations of a higher opening in the major market during the early period. Mainland stock markets continued to perform well, with the Shanghai Composite Index opening low and closing high, rising by 3.6% at the close, surpassing the 3,000 point level, and the total turnover of the Shanghai and Shenzhen stock markets once again exceeded one trillion yuan. Hong Kong stocks have been on a winning streak recently, with the index approaching the 20,000 point level, and the market turnover soaring to 300 billion yuan, reaching a new high in three and a half years. The market anticipates more stimulus policies introduced by the mainland to boost consumer and real estate markets, with the index expected to test resistance at 20,500 points, with support at the 19,500 point level.

Industry News
Orbusneich (06929) is a leading global developer and manufacturer of PCI/PTA balloons, with products sold to over 70 countries and regions worldwide. The company also specializes in coronary stent products, actively expanding its business into neurovascular intervention and structural heart disease fields. The group has established direct sales teams in 11 countries or regions, with a total of 249 sales and marketing personnel and 207 distributors as of the end of June, utilizing an extensive sales network to sell products. Affected by fluctuations in the Japanese yen exchange rate and changes in policies in some regions, the company's first-half profit fell by 25.2% to 18.828 million U.S. dollars, with revenue dropping by 3.1% to 78.91 million U.S. dollars in the period. The gross margin declined by 0.9 percentage points to 70.7% year-on-year, while the net margin fell by 7 percentage points to 23.9%. The group is integrating the operations of the German company eucatech AG acquired last year, reorganizing production lines, and expects eucatech AG to resume production and shipments in the third quarter, potentially driving performance improvement. The group has appointed a general contractor for its largest research and production facility in Hangzhou, expected to commence production in 2027, increasing the group's annual capacity by 2.4 million products at that time.

(I am a licensed person of the China Securities Regulatory Commission, and neither I nor any related person holds the above-mentioned shares).

Author: Guo Jiayao, Director of Investment of Macrohedge Asset Management